range of other major structural abnormalities and genetic syndromes (Souka et al., 1998).
failure in association with abnormalities of the heart and great arteries (Hyett et al., 1996 (Hyett et al., , 1997 von Kaisenberg et al., 1997 , Nuchal skin oedema at 10-14 weeks gestation, observed by 1998c), and (iv) venous congestion in the head and neck in ultrasonography as increased nuchal translucency (NT), is association with the constriction of the fetal body in amnion found in~70% of fetuses with trisomies 21, 18 and 13 as well rupture sequence, superior mediastinal compression found in as those with Turner's syndrome. This study investigates the diaphragmatic hernia and the narrow chest in skeletal dysplasia, possibility that one mechanism for increased translucency or failure of lymphatic drainage due to impaired fetal moveis an altered composition of the skin with a higher concenments in various neuromuscular disorders (Souka et al., 1998) .
tration of hyaluronan; large amounts of hyaluronan can
In terms of the possible role of the altered composition of lead to excessive hydration of the extracellular matrix. We the interstitial connective tissue, ultramorphological studies in isolated the hyaluronic acid binding region (HABR) from nuchal skin of fetuses with trisomy 21 showed a large amount aggrecan in the extracellular matrix of hyaline cartilage of fine flocculate precipitate around bundles of collagen fibrils and used it in a biotinylated form in combination with a (Brand-Saberi et al., 1994a) . The amount of precipitate was fluorescent probe as a marker for hyaluronan. Immunomuch lower in the skin of trisomy 18 fetuses (Brand-Saberi histochemistry was then used to examine the nuchal skin et al., 1994b) , whereas in trisomy 13 there were regions of chromosomally abnormal and normal fetuses, obtained with very little precipitate alternating with regions of high after termination of pregnancy. In fetuses with trisomy 21 concentration (von Kaisenberg et al., 1998b) . Furthermore, in there was a substantial increase in hyaluronan, whereas in the skin of trisomy 21 fetuses there is overexpression of trisomies 18 and 13 and Turner's syndrome the amount collagen type VI (von Kaisenberg et al., 1998a) . Collagen type was similar to that in chromosomally normal controls. This VI binds to hyaluronan (McDevitt et al., 1991) . Hyaluronanfinding suggests that hyaluronan may be implicated in the based extracellular matrices have open structures that entrap pathogenesis of increased NT in fetuses with trisomy large amounts of solvent and may therefore play an important 21, but the common phenotypic expression of increased role in the pathogenesis of nuchal oedema. This study investitranslucency in different chromosomal abnormalities may gates the possibility that one mechanism for increased translube the consequence of other mechanisms.
cency is an altered composition of the skin with abundance of Key words: extracellular matrix/hyaluronan/nuchal transhyaluronan using a highly specific technique for the detection lucency/trisomies/Turner's syndrome of this molecule.
Materials and methods Introduction

Fetal tissues
Trisomy 21 and all other major chromosomal abnormalities Surgical termination of pregnancy was performed at the request of are associated with interstitial oedema in the neck region the parents for medical or psychosocial reasons. Nuchal skin from which can be visualized by ultrasound examination at 10-14 fetuses with trisomy 21 (n ϭ 4), trisomy 18 (n ϭ 4), trisomy 13 weeks gestation as increased fetal nuchal translucency (NT) (n ϭ 3), Turner's syndrome (n ϭ 2), and normal controls (n ϭ 2) at thickness (Nicolaides et al., 1992) . Fetal NT thickness has 11-18 weeks gestation was examined. Written informed consent was now been combined with maternal age to provide the most obtained, the study was approved by the hospital ethical committee effective method of early screening for chromosomal abnormaland tissue collection was made in accordance with the Polkinghorne ities (Snijders et al., 1998). Increased NT is also observed in guidelines on the research use of fetal tissue (Polkinghorne, 1989) . The specificity of the hyaluronan binding region was examined a high proportion of fetuses with cardiac defects, and a wide histochemically using a chicken model with known amount and HABR and an excess of soluble hyaluronan did not show any staining. The sections were examined by epi-fluorescence microscopy and distribution of hyaluronan.
photographed using TMY-400 black-and-white film (Ektachrome).
Preparation of the biotinylated hyaluronan binding region The hyaluronan binding region (HABR) was isolated from bovine
Results cartilage by combination of hydroxyapatite chromatography and gel filtration under associative and dissociative conditions as previously
In the chromosomally normal fetuses, hyaluronan was detected described (Tammi et al., 1994) . Briefly, proteoglycans were extracted using a biotinylated fragment of aggrecan containing the from cartilage obtained from a local butchery, using 4 mol/l guanidium HABR. Hyaluronan was localized mainly in the upper dermis, chloride in 0.05 mol/l sodium acetate (pH 5.8). After stirring overnight and, to a lesser extent, in the epidermis; the subcutis and the at 4°C, the solution was cleared by centrifugation and filtration. basement membrane were barely stained (Figure 1) . Subsequently, 200 mg hyaluronan (Healon, Pharmacia, Freiburg,  In trisomy 21 fetuses there was strong staining of hyaluronan, Germany) per 100 g cartilage was added. Subsequently, dialysis especially in the dermis and to a lesser extent in the subcutis against water was done overnight at 4°C. After trypsin digestion, the (Figure 1a,b) . In fetuses with trisomy 18 the nuchal skin material was applied to a hydroxyapatite column (BioRad, Munich, Germany) equilibrated with 0.003 mol/l sodium phosphate buffer (pH showed disseminated staining, mostly in the dermis, but this 6.8). After washing, bound material was eluted with 0.4 mol/l sodium was less intense than in trisomy 21 (Figure 1c) . In skin from phosphate buffer (pH 7.0). The fractions were frozen at -80°C or trisomy 13 fetuses there was an irregular pattern of hyaluronan further processed.
with a cluster-like distribution in the upper and lower dermis,
The eluted fraction was concentrated by filtration using an Amicon subcutis and basement membrane; the epidermis showed no filtration chamber with a Diaflo PM30 membrane (Amicon, Beverly, staining ( Figure 1d ). In the skin from fetuses with Turner's MA, USA). Gel filtration over Sephacryl S1000 (Pharmacia) was syndrome, staining was restricted to the upper dermis and did done in 0.5 mol/l sodium acetate buffer (pH 7.0). Fractions near the not differ from fetuses with normal karyotype in its distribution exclusion volume were pooled, dialysed against water and lyophilized.
to (Figure 1e,f) .
Biotinylation of the hyaluronic acid-hyaluronan binding region com-
The distribution of hyaluronan relates to our previous plex using N-hydroxysuccinimide (NHS)-biotin was carried out immunohistochemical findings on the distribution of collagen (Ripellino et al., 1985) . NHS-biotin 1 mg dissolved in dimethylsulphoxide (DMSO) was mixed with 1 mg of the hyaluronic acidtype VI (Table I) , which showed a similar distribution in the hyaluronan binding region complex dissolved in 0.1 mol/l sodium dermis, subcutis and basement membrane (von Kaisenberg phosphate buffer (pH 7.4) and incubated at room temperature for 4 h.
et al., 1998b).
After dialysis against water and lyophilization, the material was applied to a Sephacryl S400-HR (Pharmacia) column. Separation of hyaluronan binding region from hyaluronic acid was done under Discussion dissociative conditions (4 mol/l guanidinium chloride in 50 mmol/l
We examined the distribution of hyaluronan in the nuchal skin sodium acetate buffer, pH 5.8). Fractions were pooled, dialysed of chromosomally abnormal fetuses and normal age-matched against water and stored at -80°C, either lyophilized or dissolved controls using a biotinylated probe for hyaluronan (HABR) in phosphate-buffered saline (PBS) containing 6% bovine serum albumin (BSA). prepared from cartilage.
The efficiency of the chromatographic steps was confirmed by dot
In fetuses with trisomy 21, but not in trisomies 18 or 13 blotting of different bound and non-bound fractions using a monoand Turner's syndrome, hyaluronan is abundant in the nuchal clonal antibody against the HABR (1C6) as described (Sorrell et al., skin, especially in the dermis. These findings suggest that 1999). Protein content was determined by the Bradford method hyaluronan may be implicated in the pathogenesis of increased (BioRad; Bradford, 1976) abnormalities may be the consequence of other mechanisms (von Kaisenberg et al., 1999b) . It is of interest that also in Histochemistry postnatal life, conditions with increased amounts of hyaluronan, Skin was taken from the nuchal region of fetuses immediately after such as inflammatory rheumatic diseases or cirrhotic liver surgical termination of pregnancy and was then embedded in Tissue disease (Engström-Laurent et al., 1989) , are associated with Tek (Leica, Bensheim, Germany) without prior fixation and frozen in liquid nitrogen, as described earlier (von Kaisenberg et al., 1998a,b). interstitial oedema (Hay, 1991) .
Controls were carried out on paraformaldehyde-fixed sections that
The wide distribution and prolonged presence of hyaluronan did not differ in result. Frozen sections (20 µm) were collected on in the skin of trisomy 21 fetuses may be the consequence of gelatin-coated slides. After air drying, cryosections of nuchal skin increased synthesis or decreased degradation. The metabolism from trisomic and normal fetuses were treated with 1% BSA in of hyaluronan is a complex process that involves hyaluronan 0.1 mol/l potassium phosphate buffer (pH 7.6) for 10 min to block synthase, the hyaladherin CD44 receptor, and catabolic non-specific binding, and afterwards incubated with biotinylated enzymes. Known hyaluronan synthases are HAS1 (Itano and HABR for 1 h. The HABR is the region of the core protein of Kimata, 1996; Shyjan et al., 1996) , HAS2 (Watanabe and aggrecan, which binds the hyaluronan side chains in association with Yamagucchi, 1996) , and HAS3 (Povey, 1996) (von Kaisenberg et al., 1998b) . nd ϭ not determined.
1989) and it is therefore unlikely to be altered in trisomy 21.
protects against free radical mediated degradation of hyaluronan, is encoded by chromosome 21 (21q22.1) (De La Torre Catabolic enzymes involved in hyaluronan degradation, located predominantly in the liver, include hyaluronidase, glucosaminiet al., 1996) . Consequently, the increased amount of hyaluronan in the skin of trisomy 21 fetuses (i.e. having three copies of dase, acetylhexosaminidase and a number of glucuronidases (Nakamura et al., 1996) . The genes for these enzymes have the gene relating to superoxide dismutase instead of two) may be due to decrease in degradation. not yet been mapped. However, superoxide dismutase, which
